Publication | Closed Access

Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: Toxicity analysis of RTOG 95-17

Surgical OncologyBreast OncologyPhase Ii TrialRadiation TherapyMedicineBrachytherapySelect Breast CancerBreast CancerOncologyRadiation OncologyRtog 95-17RadiologyHealth Sciences